Can eye drops prevent vision problems in ovarian cancer treatment?
NCT ID NCT06365853
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 30 times
Summary
This study looks at how to reduce eye problems caused by the drug mirvetuximab soravtansine in people with recurrent ovarian cancer. About 100 participants will receive the drug and be monitored for eye side effects, with some using special eye drops to try to prevent them. The goal is to find the best way to manage these side effects while continuing treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AZ Sint-Lucas /ID# 269307
ACTIVE_NOT_RECRUITINGGhent, Oost-Vlaanderen, 9000, Belgium
-
Beaumont Hospital /ID# 268864
COMPLETEDDublin, D09 XR63, Ireland
-
Blacktown Hospital /ID# 269305
ACTIVE_NOT_RECRUITINGBlacktown, New South Wales, 2148, Australia
-
CHU de Liege /ID# 269312
COMPLETEDLiège, 4000, Belgium
-
Centre Hospitalier Régional Universitaire de Tours - Hôpital Bretonneau /ID# 269301
ACTIVE_NOT_RECRUITINGTours, Indre-et-Loire, 37000, France
-
Clinique Victor Hugo Le Mans /ID# 269985
ACTIVE_NOT_RECRUITINGLe Mans, Sarthe, 72000, France
-
Duke Cancer Institute /ID# 269342
RECRUITINGDurham, North Carolina, 27710, United States
-
GH Diaconesses Croix Saint-Simon /ID# 269329
ACTIVE_NOT_RECRUITINGParis, 75020, France
-
Holy Cross Hospital - Silver Spring /ID# 269344
RECRUITINGSilver Spring, Maryland, 20910, United States
-
Holy Name Medical Center /ID# 269340
RECRUITINGTeaneck, New Jersey, 07666, United States
-
Hopitaux Universitaires Paris Centre-Hopital Cochin /ID# 269330
ACTIVE_NOT_RECRUITINGParis, Paris, 75679, France
-
Hospices Civils de Lyon - Centre Hospitalier Lyon-Sud /ID# 269327
ACTIVE_NOT_RECRUITINGPierre-Bénite, Rhone, 69310, France
-
Hospital Notre-Dame Du Centre Hospitalier De L'Universite De Montreal /ID# 269314
ACTIVE_NOT_RECRUITINGMontreal, Quebec, H2L 4M1, Canada
-
Hospital San Pedro de Alcántara /ID# 269320
ACTIVE_NOT_RECRUITINGCáceres, Caceres, 10003, Spain
-
Hospital Universitario 12 de Octubre /ID# 269321
ACTIVE_NOT_RECRUITINGMadrid, 28041, Spain
-
Hospital Universitario La Paz /ID# 269302
ACTIVE_NOT_RECRUITINGMadrid, 28046, Spain
-
Hospital Universitario Ramon y Cajal /ID# 269318
ACTIVE_NOT_RECRUITINGMadrid, 28034, Spain
-
Hospital Universitario Vall de Hebron /ID# 269315
ACTIVE_NOT_RECRUITINGBarcelona, 08035, Spain
-
Hospital Universitario de Jaén /ID# 269319
ACTIVE_NOT_RECRUITINGJaén, Jaen, 23007, Spain
-
Hospital Universitario y Politecnico La Fe /ID# 269325
COMPLETEDValencia, 46026, Spain
-
Institut Paoli-Calmettes /ID# 269648
ACTIVE_NOT_RECRUITINGMarseille, Bouches-du-Rhone, 13273, France
-
Mater Misericordiae University Hospital /ID# 269334
ACTIVE_NOT_RECRUITINGDublin, D07 R2WY, Ireland
-
McGill University Health Centre - Glen Site. /ID# 269313
ACTIVE_NOT_RECRUITINGMontreal, Quebec, H4A 3J1, Canada
-
Memorial Hermann Southeast Hospital /ID# 269347
RECRUITINGHouston, Texas, 77089, United States
-
Mercy David C. Pratt Cancer Center /ID# 269350
RECRUITINGSt Louis, Missouri, 63141, United States
-
Monash Health - Monash Medical Centre /ID# 269304
ACTIVE_NOT_RECRUITINGClayton, Victoria, 3168, Australia
-
New York Oncology Hematology - Albany Cancer Center /ID# 269345
COMPLETEDAlbany, New York, 12206-5013, United States
-
Newcastle Private Hosptial /ID# 269306
ACTIVE_NOT_RECRUITINGLambton Heights, New South Wales, 2305, Australia
-
Norton Cancer Institute - St. Matthews /ID# 269070
COMPLETEDLouisville, Kentucky, 40207, United States
-
OLV Ziekenhuis Aalst /ID# 269311
ACTIVE_NOT_RECRUITINGAalst, Oost-Vlaanderen, 9300, Belgium
-
Summa Health /ID# 269349
RECRUITINGAkron, Ohio, 44304-1407, United States
-
The Center Of Hope /ID# 269348
ACTIVE_NOT_RECRUITINGReno, Nevada, 89511, United States
-
UT Southwestern Medical Center /ID# 269341
RECRUITINGDallas, Texas, 75390, United States
-
UZ Gent /ID# 269309
COMPLETEDGhent, Oost-Vlaanderen, 9000, Belgium
-
Universitair Ziekenhuis Antwerpen /ID# 269310
COMPLETEDEdegem, Antwerpen, 2650, Belgium
-
Universitair Ziekenhuis Leuven /ID# 269308
ACTIVE_NOT_RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
-
Universite de Montreal - Hopital Maisonneuve-Rosemont /ID# 268862
ACTIVE_NOT_RECRUITINGMontreal, Quebec, H1T 2M4, Canada
-
University of California Los Angeles /ID# 269339
RECRUITINGLos Angeles, California, 90095, United States
-
Usp Instituto Universitario Dexeus /ID# 269322
ACTIVE_NOT_RECRUITINGBarcelona, 08028, Spain
-
Women'S Cancer Care Associates /ID# 269980
COMPLETEDAlbany, New York, 12208, United States
Conditions
Explore the condition pages connected to this study.